---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-000205"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:48:37.122943+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals files updated investor presentation; no specific financial or operational details disclosed

## Summary
- Filing includes an updated investor presentation as of January 2026, furnished as Exhibit 99.1.
- The presentation content is not fully provided; only legal disclaimers are visible in the filing.
- No new financial results, guidance, or material events are disclosed in the filing text.
- The presentation may contain updates on commercial progress, but specifics are not available from this filing.

## SEC filing metadata
- accession: 0001683168-26-000205
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316826000205/0001683168-26-000205-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316826000205/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-000205
- JSON: https://secwatch.observer/filing/0001683168-26-000205.json
- Plain text: https://secwatch.observer/filing/0001683168-26-000205.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.